Heyholder
‹ Activism Filings

GeneOne Life Science, Inc. Q3 operating loss of KRW 5.4 billion on revenue of KRW 1.8 billion

GeneOne Life Science, Inc.· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 1.8 billion and lost KRW 5.4 billion from its main business, versus a KRW 11.7 billion loss a year earlier.

Operating profit · 3 months

KRW -5.4 billion

Key facts

Revenue (3 months)
KRW 1.8 billion
Net income (3 months)
KRW -15.4 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 5.1 billion
Revenue (year to date)
KRW 6.4 billion
Operating profit (prior-year 3 months)
KRW -11.7 billion
Operating profit (year to date)
KRW -20.6 billion
Net income (prior-year 3 months)
KRW -11.5 billion
Net income (year to date)
KRW -36.7 billion

Earlier Periodic Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.05.15[Amended] Periodic ReportKRW -2.3 billion

Comments

No comments yet

Comments from shareholders will appear here.